
Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.
Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.
The agency is considering dispensing mail-back envelopes with outpatient opioid analgesic prescriptions.
Combining nonopioid analgesics and nonpharmacologic pain management options with opioid medications can lead to better patient outcomes.
COVID-19 updates and news to know as of February 21, 2022.
The NVX-CoV2373 vaccine was evaluated in adolescents aged 12 to 17 years.
COVID-19 updates and news to know as of January 17, 2022.
COVID-19 updates and news to know as of January 3, 2022.
Take a look back at the top 10 women’s health news articles published on Drug Topics® this year.
Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.
COVID-19 updates and news to know as of December 6, 2021.
The next step in the approval process is the formal acceptance of the recommendation by CDC Director Rochelle P. Walensky, MD, MPH.
Published: April 20th 2022 | Updated: